NASDAQ

Ultragenyx Reports Fourth Quarter 2015 and Full-Year 2015 Financial Results and Corporate Update

NOVATO, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical ...

RedHill Biopharma Announces Availability of Its Annual Report on Form 20-F Through Its Website

TEL-AVIV, Israel, Feb. 25, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” ...

TESARO Announces Definitive Agreement for $155 Million Private Placement

WALTHAM, Mass., Feb. 25, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

Peregrine Pharmaceuticals Provides Update on Phase III SUNRISE Trial of Bavituximab

TUSTIN, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a ...

TESARO Announces Fourth-Quarter 2015 Operating Results

U.S. commercial launch of VARUBI® (oral rolapitant) well underwayNiraparib Phase 3 NOVA results expected ...

Dendritic Cell Vaccine Inhibits Tumor Progression in Preclinical Liver Cancer Model

NEW YORK, Feb. 25, 2016 (GLOBE NEWSWIRE) -- Saronic Biotechnology, Inc. today announces publication ...

Celldex Reports Fourth Quarter and Year-End 2015 Results

HAMPTON, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported ...

Celldex Reports Fourth Quarter and Year-End 2015 Results

HAMPTON, N.J., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported ...